Topic:Health & Pharma Panel Discussion with Tim Hawkey, Laura Florence and Collette Douaihy
About Tim:
Born into an advertising family, Tim spent his first 22 years trying to avoid a life in advertising. He may have failed at that, but he’s made up for it with a meteoric, award-winning career. After bringing AREA 23 to Health Agency of the Year, accolades at nearly every award show under the sun, including Cannes Lions, Tim has solidified the agency’s reputation as the destination for creativity.
“Let’s not just do great work, let’s change this industry,” says Tim, who is driven to elevate creativity in the pharma space, at AREA 23, and beyond. He believes there is no good reason why pharma creative has to be bad. “If the work you are doing isn’t scaring you and your clients, and their lawyers, then you probably aren’t doing it right.”
It’s this drive to push the limits that invites much attention to the work of Tim and his teams, earning hundreds of trophies in the last 5 years from Clios, The One Show, D&AD, as well as garnering 50+ Lions at Cannes in the last 5 years, including the Grand Prix for Innovation, Radio and Audio, and Pharma, and achieving Health Agency of the Year in 2017, 2020, and 2021 and Health Network of the Year in 2018, 2020, and 2021.
“Let’s not just do great work, let’s change this industry,” says Tim, who is driven to elevate creativity in the pharma space, at AREA 23, and beyond. He believes there is no good reason why pharma creative has to be bad. “If the work you are doing isn’t scaring you and your clients, and their lawyers, then you probably aren’t doing it right.”
It’s this drive to push the limits that invites much attention to the work of Tim and his teams, earning hundreds of trophies in the last 5 years from Clios, The One Show, D&AD, as well as garnering 50+ Lions at Cannes in the last 5 years, including the Grand Prix for Innovation, Radio and Audio, and Pharma, and achieving Health Agency of the Year in 2017, 2020, and 2021 and Health Network of the Year in 2018, 2020, and 2021.